Transactions Summary for September 2025

Here are the main operations carried out in September 2025:

  • I sold my entire position in MEDIOBANCA (subject to a takeover bid/tender offer by MPS) with a gain of +100%, not counting the dividends received over the years.
  • With the proceeds, I bought MPS shares with the intention of increasing my dividend flow.
  • I sold CALTAGIRONE EDITORE with a profit of +9% plus one dividend collected.
  • I sold DANIELI with a profit of +42% plus several dividends collected.
  • I sold TAMBURI and GAROFALO HEALTHCARE essentially at par (break-even), having collected some dividends.
  • Two certificates were reimbursed to me (DE000UJ6RCE3, CH1453358595); with the proceeds, I purchased the following certificates: CH1467586934, CH1476719021, DE000VG36PH5, CH1453369014.
Description Title Isin Sign
Compravendita titoli DANIELI & C. RSP IT0000076486 V
Compravendita titoli TAMBURI INC PARTN IT0003153621 V
Compravendita titoli CALTAGIRONE EDITORE IT0001472171 V
Compravendita titoli GAROFALO H CARE IT0005345233 V
Compravendita titoli CALTAGIRONE EDITORE IT0001472171 V
Compravendita titoli BSKT/LEON 28 CH1467586934 A
Compravendita titoli BSKT/LEON 29 CH1476719021 A
Compravendita titoli VON EXPE27 DE000VG36PH5 A
Compravendita titoli VON EXPE27 DE000VG36PH5 V
Compravendita titoli BSKT/LEON 28 CH1453369014 A
Compravendita titoli MEDIOBANCA IT0000062957 V
Compravendita titoli BANCA MPS IT0005508921 A
Dividendo VON EXPE26 DE000VM8ML33  
Dividendo ENI IT0003132476  
Dividendo ISHS USD EM BD EUR IE00B9M6RS56  
Dividendo **UBS EXPE28 DE000UJ6RCE3  
Dividendo BSKT/LEON 28 CH1453369014  
Dividendo **BSKT/LEON 27 CH1453358595  
Dividendo INVE S&P 500 USD IE00BYML9W36  
Dividendo ALPHABET-A US02079K3059  
Dividendo UNILEVER GB00B10RZP78  
Dividendo JPM ETF GLB USD IE0003UVYC20  
Dividendo GBL X NAS USD- IE00BM8R0J59  
Dividendo XTR2 EHYCB 1DD LU1109942653  
Dividendo VON EXPE27 DE000VG36PH5  
Dividendo STHY IE00B7N3YW49  
Rimborso **UBS EXPE28 DE000UJ6RCE3  
Rimborso **BSKT/LEON 27 CH1453358595  

Leave a Reply

Your email address will not be published. Required fields are marked *